Demo Data from EDBT 2026 / reviewers in the wild / expert
Caroline Labelle
dblp:244/8697
· DBLP profile ↗
1ranked-venue papers
1as first author
0since 2021 · last 2019
0000-0001-9990-586XORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 87% Medical and health informatics · 13% |
Topics — the 2 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › biostatistics
dose-response analysis |
0.4 | 1 | 2019 | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose-response experiments · Bioinform. 2019 |
Bioinformatics and computational biology
drug discovery |
0.4 | 1 | 2019 | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose-response experiments · Bioinform. 2019 |
Methods — techniques the papers use, named apart from their topics
bayesian inference · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2019 | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose-response experimentsabstractMOTIVATION: The efficacy of a chemical compound is often tested through dose-response experiments from which efficacy metrics, such as the IC50, can be derived. The Marquardt-Levenberg algorithm (non-linear regression) is commonly used to compute estimations for these metrics. The analysis are however limited and can lead to biased conclusions. The approach does not evaluate the certainty (or uncertainty) of the estimates nor does it allow for the statistical comparison of two datasets. To compensate for these shortcomings, intuition plays an important role in the interpretation of results and the formulations of conclusions. We here propose a Bayesian inference methodology for the analysis and comparison of dose-response experiments. RESULTS: Our results well demonstrate the informativeness gain of our Bayesian approach in comparison to the commonly used Marquardt-Levenberg algorithm. It is capable to characterize the noise of dataset while inferring probable values distributions for the efficacy metrics. It can also evaluate the difference between the metrics of two datasets and compute the probability that one value is greater than the other. The conclusions that can be drawn from such analyzes are more precise. AVAILABILITY AND IMPLEMENTATION: We implemented a simple web interface that allows the users to analyze a single dose-response dataset, as well as to statistically compare the metrics of two datasets. Caroline Labelle, Anne Marinier, Sébastien Lemieux |
Bioinform. | 1 |